164 related articles for article (PubMed ID: 23402745)
1. Activated intestinal macrophages in patients with cirrhosis release NO and IL-6 that may disrupt intestinal barrier function.
Du Plessis J; Vanheel H; Janssen CE; Roos L; Slavik T; Stivaktas PI; Nieuwoudt M; van Wyk SG; Vieira W; Pretorius E; Beukes M; Farré R; Tack J; Laleman W; Fevery J; Nevens F; Roskams T; Van der Merwe SW
J Hepatol; 2013 Jun; 58(6):1125-32. PubMed ID: 23402745
[TBL] [Abstract][Full Text] [Related]
2. Haemodynamic derangement in human immunodeficiency virus-infected patients with hepatitis C virus-related cirrhosis: the role of bacterial translocation.
Montes-de-Oca M; Blanco MJ; Marquez M; Soto MJ; Fernandez-Gutiérrez C; Rodriguez-Ramos C; Giron-Gonzalez JA
Liver Int; 2011 Jul; 31(6):850-8. PubMed ID: 21645216
[TBL] [Abstract][Full Text] [Related]
3. Uncovering the molecular events associated with increased intestinal permeability in liver cirrhosis: the pivotal role of enterocyte tight junctions and future perspectives.
Assimakopoulos SF; Charonis AS
J Hepatol; 2013 Nov; 59(5):1144-6. PubMed ID: 23928410
[No Abstract] [Full Text] [Related]
4. Large intestine permeability is increased in patients with compensated liver cirrhosis.
Pijls KE; Koek GH; Elamin EE; de Vries H; Masclee AA; Jonkers DM
Am J Physiol Gastrointest Liver Physiol; 2014 Jan; 306(2):G147-53. PubMed ID: 24264047
[TBL] [Abstract][Full Text] [Related]
5. Reply to: "Uncovering the molecular events associated with increased intestinal permeability in liver cirrhosis: The pivotal role of enterocyte tight junctions and future perspectives".
du Plessis J; van der Merwe SW
J Hepatol; 2013 Nov; 59(5):1146-7. PubMed ID: 23928405
[No Abstract] [Full Text] [Related]
6. Altered intestinal tight junctions' expression in patients with liver cirrhosis: a pathogenetic mechanism of intestinal hyperpermeability.
Assimakopoulos SF; Tsamandas AC; Tsiaoussis GI; Karatza E; Triantos C; Vagianos CE; Spiliopoulou I; Kaltezioti V; Charonis A; Nikolopoulou VN; Scopa CD; Thomopoulos KC
Eur J Clin Invest; 2012 Apr; 42(4):439-46. PubMed ID: 22023490
[TBL] [Abstract][Full Text] [Related]
7. Activated intestinal macrophages in patients with cirrhosis release NO and IL-6 that may disrupt intestinal barrier function.
Goode EC; Warburton RC; Gelson WT; Watson AJ
Gastroenterology; 2013 Dec; 145(6):1481-4. PubMed ID: 24409494
[No Abstract] [Full Text] [Related]
8. Epithelial inducible nitric oxide synthase causes bacterial translocation by impairment of enterocytic tight junctions via intracellular signals of Rho-associated kinase and protein kinase C zeta.
Wu LL; Chiu HD; Peng WH; Lin BR; Lu KS; Lu YZ; Yu LC
Crit Care Med; 2011 Sep; 39(9):2087-98. PubMed ID: 21552122
[TBL] [Abstract][Full Text] [Related]
9. Presence of inducible nitric oxide synthase, nitrotyrosine, CD68, and CD14 in the small intestine in celiac disease.
ter Steege J; Buurman W; Arends JW; Forget P
Lab Invest; 1997 Jul; 77(1):29-36. PubMed ID: 9251676
[TBL] [Abstract][Full Text] [Related]
10. Increased lipopolysaccharide binding protein in cirrhotic patients with marked immune and hemodynamic derangement.
Albillos A; de la Hera A; González M; Moya JL; Calleja JL; Monserrat J; Ruiz-del-Arbol L; Alvarez-Mon M
Hepatology; 2003 Jan; 37(1):208-17. PubMed ID: 12500206
[TBL] [Abstract][Full Text] [Related]
11. Bacterial translocation in HIV-infected patients with HCV cirrhosis: implication in hemodynamic alterations and mortality.
de Oca Arjona MM; Marquez M; Soto MJ; Rodriguez-Ramos C; Terron A; Vergara A; Arizcorreta A; Fernandez-Gutierrez C; Giron-González JA
J Acquir Immune Defic Syndr; 2011 Apr; 56(5):420-7. PubMed ID: 21266909
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide mediates lung vascular permeability and lymph-borne IL-6 after an intestinal ischemic insult.
Breithaupt-Faloppa AC; Vitoretti LB; Coelho FR; dos Santos Franco AL; Domingos HV; Sudo-Hayashi LS; Oliveira-Filho RM; Tavares de Lima W
Shock; 2009 Jul; 32(1):55-61. PubMed ID: 18838940
[TBL] [Abstract][Full Text] [Related]
13. Monocyte and M1 Macrophage-induced Barrier Defect Contributes to Chronic Intestinal Inflammation in IBD.
Lissner D; Schumann M; Batra A; Kredel LI; Kühl AA; Erben U; May C; Schulzke JD; Siegmund B
Inflamm Bowel Dis; 2015 Jun; 21(6):1297-305. PubMed ID: 25901973
[TBL] [Abstract][Full Text] [Related]
14. Comparative nitric oxide production by LPS-stimulated monocyte-derived macrophages from Ovis canadensis and Ovis aries.
Sacco RE; Waters WR; Rudolph KM; Drew ML
Comp Immunol Microbiol Infect Dis; 2006 Jan; 29(1):1-11. PubMed ID: 16460804
[TBL] [Abstract][Full Text] [Related]
15. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide prevent inducible nitric oxide synthase transcription in macrophages by inhibiting NF-kappa B and IFN regulatory factor 1 activation.
Delgado M; Munoz-Elias EJ; Gomariz RP; Ganea D
J Immunol; 1999 Apr; 162(8):4685-96. PubMed ID: 10202009
[TBL] [Abstract][Full Text] [Related]
16. Bacterial DNA activates cell mediated immune response and nitric oxide overproduction in peritoneal macrophages from patients with cirrhosis and ascites.
Francés R; Muñoz C; Zapater P; Uceda F; Gascón I; Pascual S; Pérez-Mateo M; Such J
Gut; 2004 Jun; 53(6):860-4. PubMed ID: 15138214
[TBL] [Abstract][Full Text] [Related]
17. Impaired immune functions of monocytes and macrophages in Whipple's disease.
Moos V; Schmidt C; Geelhaar A; Kunkel D; Allers K; Schinnerling K; Loddenkemper C; Fenollar F; Moter A; Raoult D; Ignatius R; Schneider T
Gastroenterology; 2010 Jan; 138(1):210-20. PubMed ID: 19664628
[TBL] [Abstract][Full Text] [Related]
18. The protective effect of enteric glial cells on intestinal epithelial barrier function is enhanced by inhibiting inducible nitric oxide synthase activity under lipopolysaccharide stimulation.
Xiao WD; Chen W; Sun LH; Wang WS; Zhou SW; Yang H
Mol Cell Neurosci; 2011 Feb; 46(2):527-34. PubMed ID: 21182950
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-1beta and inducible form of nitric oxide synthase expression in early syngeneic islet transplantation.
Montolio M; Biarnés M; Téllez N; Escoriza J; Soler J; Montanya E
J Endocrinol; 2007 Jan; 192(1):169-77. PubMed ID: 17210754
[TBL] [Abstract][Full Text] [Related]
20. The activity of inducible nitric oxide synthase in rejected skin xenografts is selectively inhibited by a factor produced by grafted cells.
Holán V; Pindjáková J; Zajícová A; Krulová M; Zelezná B; Matousek P; Svoboda P
Xenotransplantation; 2005 May; 12(3):227-34. PubMed ID: 15807773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
